GeneReach Biotechnology (4171) — Free Cash Flow Generation Index
GeneReach Biotechnology (4171) has a Free Cash Flow Generation Index of 0.62x as of December 2025. Free cash flow of NT$7.47 Million represents 1% of operating cash flow (NT$12.05 Million). Read total liabilities of GeneReach Biotechnology for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
GeneReach Biotechnology Free Cash Flow Generation Index (2018–2022)
Historical FCF Generation Index trend for GeneReach Biotechnology across 4 annual periods. Explore 4171 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for GeneReach Biotechnology (2018–2022)
Year-by-year Free Cash Flow Generation Index for GeneReach Biotechnology. For the full company profile including market capitalisation, see 4171 market cap.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.87x | NT$312.73 Million | NT$357.63 Million | NT$44.90 Million | ▼ -8.4% |
| 2021 | 0.95x | NT$333.20 Million | NT$348.99 Million | NT$15.79 Million | ▲ +54.5% |
| 2020 | 0.62x | NT$104.95 Million | NT$169.82 Million | NT$64.87 Million | ▲ +3.3% |
| 2018 | 0.60x | NT$3.44 Million | NT$5.74 Million | NT$2.31 Million | — |